We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+8.42%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$160M
AUM Growth
+$19.5M
Cap. Flow
+$10.9M
Cap. Flow %
6.8%
Top 10 Hldgs %
27.73%
Holding
76
New
19
Increased
19
Reduced
25
Closed
10

Sector Composition

Rank Sector Weight
1 Healthcare 89.14%
2 Financials 2.09%
3 Industrials 0.78%
4 Consumer Staples 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HRC
51
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$1.35M 0.84%
+35,000
New +$1.35M
INCY icon
52
Incyte
INCY
$24.5B
$1.32M 0.83%
24,750
+9,750
+65% +$605K
GMED icon
53
Globus Medical
GMED
$11.4B
$1.32M 0.82%
+49,538
New +$1.18M
MDVN
54
DELISTED
MEDIVATION, INC.
MDVN
$1.29M 0.8%
40,000
-60,000
-60% -$2.21M
NXTM
55
DELISTED
NxStage Medical Inc.
NXTM
$1.27M 0.8%
100,000
+59,428
+146% +$775K
TW
56
DELISTED
TOWERS WATSON & CO COM STK CL A (DE)
TW
$1.25M 0.78%
+11,000
New +$1.28M
HTWR
57
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
$1.22M 0.76%
13,000
-2,000
-13% -$195K
CCRN
58
DELISTED
Cross Country Healthcare
CCRN
$1.21M 0.76%
150,000
ICLR icon
59
Icon
ICLR
$12.8B
$1.19M 0.74%
+25,000
New +$1.11M
PODD icon
60
Insulet
PODD
$10B
$1.19M 0.74%
25,000
-9,700
-28% -$429K
ACHC icon
61
Acadia Healthcare
ACHC
$2.9B
$1.13M 0.7%
25,000
-20,000
-44% -$987K
AMN icon
62
AMN Healthcare
AMN
$1.28B
$1.03M 0.64%
75,106
-17,858
-19% -$257K
OREX
63
DELISTED
Orexigen Therapeutics, Inc.
OREX
$807K 0.5%
+12,415
New +$840K
PTLA
64
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$793K 0.5%
30,600
+5,600
+22% +$149K
ICPT
65
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$660K 0.41%
+2,000
New +$675K
VIRX
66
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$417K 0.26%
+300
New +$349K
AON icon
67
Aon
AON
$75.6B
-15,000
Closed -$1.26M
BDX icon
68
Becton Dickinson
BDX
$49.4B
-13,325
Closed -$1.44M
BMRN icon
69
BioMarin Pharmaceuticals
BMRN
$13.5B
-12,000
Closed -$844K
CI icon
70
Cigna
CI
$72.4B
-25,000
Closed -$2.19M
DVA icon
71
DaVita
DVA
$11.4B
-35,000
Closed -$2.22M
MRSH
72
Marsh
MRSH
$91.3B
-25,000
Closed -$1.21M
UNH icon
73
UnitedHealth
UNH
$361B
-35,000
Closed -$2.64M
WCG
74
DELISTED
Wellcare Health Plans, Inc.
WCG
-27,300
Closed -$1.92M
ESRX
75
DELISTED
Express Scripts Holding Company
ESRX
-44,700
Closed -$3.14M

Similar funds

Sivik Global Healthcare's Q1 2014 Portfolio in Review

As of Q1 2014, Sivik Global Healthcare held 76 positions worth $160M, up 14% from $141M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Sivik Global Healthcare deployed $10.9M of net new capital in Q1 2014, opening 19 new positions and adding to 19 existing holdings. Its largest new stake was Elevance Health: 34,670 shares worth $3.45M.

By sector, the portfolio is most concentrated in Healthcare at 89% of assets, up from 87% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was MEDIVATION, INC., an estimated $2.21M trimmed.

  • Sivik Global Healthcare's largest Q1 2014 buy was Elevance Health: 34,670 shares worth $3.45M.
  • Sivik Global Healthcare added most to Universal American Corp in Q1 2014, an estimated $1.9M increase.
  • Sivik Global Healthcare's biggest Q1 2014 reduction was MEDIVATION, INC., cutting an estimated $2.21M.
  • Sivik Global Healthcare fully exited Express Scripts Holding Company in Q1 2014, selling an estimated $3.14M.
  • Sivik Global Healthcare's ten largest holdings make up 28% of its $160M portfolio in Q1 2014.
  • Sivik Global Healthcare opened 19 new positions and closed 10 in Q1 2014.
  • Sivik Global Healthcare's portfolio value rose 14% quarter-over-quarter to $160M.

Based on Sivik Global Healthcare's 13F filing for Q1 2014, filed 10 Apr 2014.